Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Lyell Immunopharma, Inc. has filed 330 SEC EDGAR filings since 20 Mar 2020

SEC filing history

Showing 26-50 of 330 matching filings.

Per page
25
Current page
2
EFFECT File 333-294884

EFFECT filing

Filing date
14 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
13 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-294884

UPLOAD filing

Filing date
08 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Mar 2026
Reporting date
09 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
16 Mar 2026
Reporting date
09 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
09 Mar 2026
Reporting date
06 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
09 Mar 2026
Reporting date
06 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Feb 2026
Reporting date
11 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Feb 2026
Reporting date
11 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Feb 2026
Reporting date
11 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Feb 2026
Reporting date
09 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Feb 2026
Reporting date
09 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Feb 2026
Reporting date
09 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Feb 2026
Reporting date
10 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Feb 2026
Reporting date
10 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Feb 2026
Reporting date
10 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jan 2026
Reporting date
24 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-291970

424B5

Filing date
18 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-291970

EFFECT filing

Filing date
15 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
11 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .